The structural characterization of the ouabain-like sodium pump inhibitor i
n mammals (so-called 'endogenous ouabain') has long been hindered by the pa
ucity of the sample material. While many microscale structural analyses, in
cluding LC/MS and sugar analysis, could not differentiate 'endogenous ouaba
in' from ouabain, our past nanogram-scale 'pentanaphthoylation' followed by
HPLC and circular dichroic spectroscopy (CD) had thought to have distingui
shed the two. 'Endogenous ouabain' has since been considered as a subtle st
ructural isomer of ouabain. However, further search for endogenous ouabain
has now shown that this is not the case. The factors responsible for the un
successful characterization for several decades were a series of unexpected
reactions, including formation of mixtures of ouabain berates and glycerol
naphthoates. The in vivo species giving rise to the reported biological ac
tivities of hypothalamic inhibitory factor (HIF) remains to be clarified in
full.